Introduction I recently gave a presentation at “Retina Day,” a meeting of retina specialists that occurs in conjunction with the Annual Meeting of the American Academy of Ophthalmology. I know many weren’t able to be there, so I want to briefly

All I remember is sprinting across the rugby field at full speed to tackle a runner charging in to score. From what others later told me, the opposing player’s knee struck my head as I went in for the tackle and I was

Age-related macular degeneration (ARMD) is the third most common cause of blindness worldwide. Treatment options for ARMD are not only limited, but are aimed primarily at decreasing the rate of vision loss, as little can be done to restore vision that

So often as physicians and patients we become frustrated at seemingly ridiculous prices for medications that likely are produced for a fraction of the cost. We view pharmaceutical companies as tyrannical price-gougers that profit from patients, and from patents, at

As part of the ARVO 2012 Entrepreneurship in Ophthalmology symposium, we at eyesteve.com were impressed with start-up Oculeve for its innovative solution to dry eye disease. Estimated to affect more than 20 million Americans, with 1.6 million having the most

Published in this week’s Nature Photonics, researchers at Stanford University have taken the next innovative step in treating retinal disease with a wire-free, battery-free bionic eye. Several forms of retinal implants have been in development for over a year, but

ARVO Day #1 – Saturday From identifying unmet needs and product concept to intellectual property and commercialization, today’s ARVO education course provided invaluable information to entrepreneurs hoping to have their idea become extremely $$$valuable$$$. The morning presentations provided the basic